Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies

Multiple Sclerosis, Relapsing-Remitting trial results

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • TG Therapeutics Investigational Trial Site Pasadena, California, United States
  • TG Therapeutics Investigational Trial Site Aurora, Colorado, United States
  • TG Therapeutics Investigational Trial Site Lexington, Kentucky, United States
  • TG Therapeutics Investigational Trial Site Columbus, Ohio, United States
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Dignity Health Medical Foundation Carmichael, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 16 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Phoenix, Arizona, United States
View all 115 locations